223 related articles for article (PubMed ID: 15591638)
1. Neuroprotective role of testosterone in the nervous system.
Białek M; Zaremba P; Borowicz KK; Czuczwar SJ
Pol J Pharmacol; 2004; 56(5):509-18. PubMed ID: 15591638
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of testosterone on regenerating spinal cord motoneurons in rats.
Tehranipour M; Moghimi A
J Mot Behav; 2010; 42(3):151-5. PubMed ID: 20363715
[TBL] [Abstract][Full Text] [Related]
3. Testosterone replacement therapy for the treatment of neurological and neuropsychiatric disorders.
Gold SM; Voskuhl RR
Curr Opin Investig Drugs; 2006 Jul; 7(7):625-30. PubMed ID: 16869115
[TBL] [Abstract][Full Text] [Related]
4. Neurotherapeutic action of testosterone on hamster facial nerve regeneration: temporal window of effects.
Tanzer L; Jones KJ
Horm Behav; 2004 May; 45(5):339-44. PubMed ID: 15109908
[TBL] [Abstract][Full Text] [Related]
5. Effects of neonatal and prepubertal hormonal manipulations upon estrogen neuroprotection of the nigrostriatal dopaminergic system within female and male mice.
Anderson LI; Leipheimer RE; Dluzen DE
Neuroscience; 2005; 130(2):369-82. PubMed ID: 15664693
[TBL] [Abstract][Full Text] [Related]
6. Testosterone induces neuroprotection from oxidative stress. Effects on catalase activity and 3-nitro-L-tyrosine incorporation into alpha-tubulin in a mouse neuroblastoma cell line.
Chisu V; Manca P; Lepore G; Gadau S; Zedda M; Farina V
Arch Ital Biol; 2006 May; 144(2):63-73. PubMed ID: 16642786
[TBL] [Abstract][Full Text] [Related]
7. Androgens activate mitogen-activated protein kinase signaling: role in neuroprotection.
Nguyen TV; Yao M; Pike CJ
J Neurochem; 2005 Sep; 94(6):1639-51. PubMed ID: 16011741
[TBL] [Abstract][Full Text] [Related]
8. The stress system in the human brain in depression and neurodegeneration.
Swaab DF; Bao AM; Lucassen PJ
Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
[TBL] [Abstract][Full Text] [Related]
9. Bak Foong protects dopaminergic neurons against MPTP-induced neurotoxicity by its anti-apoptotic activity.
Liu B; Xie JX; Tsang LL; Rowlands DK; Ho LS; Gou YL; Chung YW; Chan HC
Cell Biol Int; 2008 Jan; 32(1):86-92. PubMed ID: 17920944
[TBL] [Abstract][Full Text] [Related]
10. Exogenous testosterone prevents motoneuron atrophy induced by contralateral motoneuron depletion.
Fargo KN; Sengelaub DR
J Neurobiol; 2004 Sep; 60(3):348-59. PubMed ID: 15281072
[TBL] [Abstract][Full Text] [Related]
11. Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice.
Liu B; Dluzen DE
Neuroendocrinology; 2006; 83(5-6):295-302. PubMed ID: 16926530
[TBL] [Abstract][Full Text] [Related]
12. Potential neuroprotective effect of low dose whole-body gamma-irradiation against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity in C57 mice.
Liang Y; Li S; Zou Q; Su B
Neurosci Lett; 2006 Jun; 400(3):213-7. PubMed ID: 16540245
[TBL] [Abstract][Full Text] [Related]
13. A novel neurotrophic agent, T-817MA [1-{3-[2-(1-benzothiophen-5-yl) ethoxy] propyl}-3-azetidinol maleate], attenuates amyloid-beta-induced neurotoxicity and promotes neurite outgrowth in rat cultured central nervous system neurons.
Hirata K; Yamaguchi H; Takamura Y; Takagi A; Fukushima T; Iwakami N; Saitoh A; Nakagawa M; Yamada T
J Pharmacol Exp Ther; 2005 Jul; 314(1):252-9. PubMed ID: 15798005
[TBL] [Abstract][Full Text] [Related]
14. Potential neuroprotective effect of t-butylhydroquinone against neurotoxicity-induced by 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) in mice.
Abdel-Wahab MH
J Biochem Mol Toxicol; 2005; 19(1):32-41. PubMed ID: 15736157
[TBL] [Abstract][Full Text] [Related]
15. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
Sriram K; Miller DB; O'Callaghan JP
J Neurochem; 2006 Feb; 96(3):706-18. PubMed ID: 16405514
[TBL] [Abstract][Full Text] [Related]
16. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X
Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease.
Watanabe Y; Himeda T; Araki T
Med Sci Monit; 2005 Jan; 11(1):RA17-23. PubMed ID: 15614202
[TBL] [Abstract][Full Text] [Related]
18. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
Brinton RD
Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
Himeda T; Kadoguchi N; Kamiyama Y; Kato H; Maegawa H; Araki T
Neuropharmacology; 2006 Mar; 50(3):329-44. PubMed ID: 16303147
[TBL] [Abstract][Full Text] [Related]
20. Progesterone: therapeutic opportunities for neuroprotection and myelin repair.
Schumacher M; Guennoun R; Stein DG; De Nicola AF
Pharmacol Ther; 2007 Oct; 116(1):77-106. PubMed ID: 17659348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
